BTIS
TEVA icon

BB&T Investment Services’s Teva Pharmaceuticals TEVA Stock Holding History

BB&T Investment Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$23K Buy
1,185
+45
+4% +$677 ﹤0.01% 770
2017
Q3 		$20K Sell
1,140
-623
-35% -$14K ﹤0.01% 721
2017
Q2 		$59K Buy
1,763
+305
+21% +$9.44K 0.01% 434
2017
Q1 		$48K Sell
1,458
-682
-32% -$23.3K 0.02% 380
2016
Q4 		$77K Buy
+2,140
New +$85.4K 0.06% 231

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

BB&T Investment Services's TEVA Position: Q4 2017 in Review

BB&T Investment Services increased its Teva Pharmaceuticals (TEVA) stake by 3.9% in Q4 2017, buying an estimated $677 and bringing the position to 1,185 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #770.

BB&T Investment Services first reported a position in TEVA in Q4 2016 and has held it in 5 quarters since. The position peaked at $77K in Q4 2016. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • BB&T Investment Services held 1,185 shares of Teva Pharmaceuticals worth $23K as of Q4 2017.
  • BB&T Investment Services bought 45 Teva Pharmaceuticals shares in Q4 2017, an estimated $677.
  • Teva Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #770 holding.
  • BB&T Investment Services first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Teva Pharmaceuticals position peaked at $77K in Q4 2016.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.